Even with average monthly water bills hovering at $100, nationwide, just $1.00 lower than the record high reached in 2025, ...
“ILI evaluates how effectively a utility delivers potable water while minimizing losses. Lower values indicate greater ...
This geophysical study conducted in the Penka-Michel region, in the West of Cameroon, analyzes the distribution of apparent ...
A new study shows China's decades-long reforestation projects, including the Great Green Wall, have altered the country's hydrology. Increased vegetation has boosted evaporation and transpiration, ...
Are GLP-1 weight loss drugs like Ozempic the miracle many have waited for, or are used guinea pigs in an experiment they’ll regret in a decade? That’s the central question of a discussion Wednesday on ...
GLP-1RA initiation in type 1 diabetes associated with lower risks of major cardiovascular events and end-stage kidney disease. Patients using GLP-1RAs more likely to achieve clinically meaningful ...
Investigator-assessed PFS improved with atirmociclib plus fulvestrant versus fulvestrant alone or everolimus/exemestane, achieving HR 0.60 and meeting the primary endpoint with clinically meaningful ...
In a recent review, a small group of patients received the injections less frequently but still maintained weight loss and health benefits. By Roni Caryn Rabin The doctor kept hearing the same story ...
A commentary by FDA officials Vinay Prasad, MD, MPH, and Martin Makary, MD, MPH, details the new system for drug approvals in the US. FDA Commissioner Martin Makary, MD, MPH, and his top deputy Vinay ...
SALT LAKE CITY--(BUSINESS WIRE)--iVeena Delivery Systems, Inc. (“iVeena”), a clinical-stage ophthalmology company developing novel pharmacologic therapies for refractive eye diseases, today announced ...
-- Company to host a live webcast event with an expert panel of clinicians during ASH -- REDWOOD CITY, Calif.--(BUSINESS WIRE)--Arcellx, Inc. (NASDAQ: ACLX), a biotechnology company reimagining cell ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results